Stay updated on IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial page.

Latest updates to the IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial page
- Check2 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3. No user-facing changes to the study details or navigation are evident.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedNew publication reference Barbour et al., 2026, Kidney International, was added, and the prior online-ahead-of-print citation for the same article was removed.SummaryDifference0.1%

- Check31 days agoChange DetectedThe page now displays revision v3.4.2 and the previous government funding notice has been removed. The core study details and user-facing content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check38 days agoChange DetectedAdded a government funding lapse notice and updated the page revision to v3.4.1, while removing the previous v3.4.0 reference.SummaryDifference0.5%

- Check45 days agoChange DetectedThe page adds a glossary toggle label and minor wording changes to QC status and FEAR Act data. A revision footer indicates version 3.4.0.SummaryDifference0.2%

- Check59 days agoChange DetectedFooter revision updated to v3.3.4 (from v3.3.3). This is a minor metadata update with no impact on the study information or navigation.SummaryDifference0.1%

Stay in the know with updates to IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial page.